Conditions Commonly Treated with IVIG Therapy
Intravenous immunoglobulin, commonly called IVIG, is a specialized therapy used to treat a variety of immune, neurologic, and hematologic conditions.
Patients are sometimes surprised to learn that two people receiving IVIG may have completely different diagnoses. That is because IVIG can play different roles depending on the condition being treated.
For some patients, IVIG replaces antibodies that the body does not produce effectively. For others, it is prescribed to help regulate an abnormal immune response that may be damaging nerves, muscles, blood cells, or other tissues.
Although IVIG is used across several areas of medicine, it is not appropriate for every condition or every patient. Different IVIG products may also have different approved indications, dosing requirements, and administration instructions.
The prescribing physician determines whether IVIG is medically appropriate based on the patient’s diagnosis, symptoms, treatment history, clinical needs, and other health factors.
At Mercy Infusion, we help patients coordinate physician-prescribed IVIG therapy, including insurance verification, prior authorization, medication access, home infusion or infusion-suite treatment, nursing, and ongoing support.
What Is IVIG Therapy?
IVIG is a preparation of immunoglobulin G, or IgG, antibodies derived from donated human plasma.
Antibodies are proteins used by the immune system to recognize and respond to infections and other substances.
During IVIG therapy, immunoglobulin is administered directly into a vein, allowing the antibodies to circulate throughout the bloodstream.
Depending on the patient’s diagnosis, IVIG may be used as:
- Antibody replacement therapy
- Immune-modulating therapy
- Treatment for certain neurologic disorders
- Treatment for selected hematologic disorders
- Part of a broader treatment plan for certain autoimmune or inflammatory conditions
The dose, frequency, and duration of treatment vary considerably based on the condition and physician’s treatment plan.
Primary Immunodeficiency
One of the most established uses of immunoglobulin therapy is for certain primary immune deficiencies.
Patients with some primary immunodeficiency disorders do not produce enough functional antibodies to protect themselves adequately against infection.
This may lead to:
- Recurrent infections
- Frequent respiratory infections
- Serious bacterial infections
- Longer recovery from illness
- Increased need for antibiotics
IVIG can provide replacement antibodies that the patient’s immune system is unable to produce effectively.
Examples of primary immune deficiencies that may involve immunoglobulin therapy include:
- Common Variable Immunodeficiency, or CVID
- X-linked agammaglobulinemia
- Certain antibody-production disorders
- Other physician-diagnosed primary humoral immunodeficiencies
For these patients, IVIG may be prescribed on an ongoing basis because the treatment provides antibody replacement rather than curing the underlying immune disorder.
Some patients receive IVIG every few weeks, while others may use subcutaneous immunoglobulin, or SCIG.
Patients interested in understanding the differences between the two treatments can read our article:
IVIG vs. SCIG: What’s the Difference?
Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Inflammatory Demyelinating Polyneuropathy, or CIDP, is a chronic neurologic disorder involving the peripheral nerves.
In CIDP, abnormal immune activity contributes to damage of myelin, the protective covering around nerves.
When myelin is damaged, nerve signals may not travel properly between the brain, spinal cord, muscles, and sensory nerves.
Symptoms of CIDP may include:
- Progressive muscle weakness
- Numbness
- Tingling
- Difficulty walking
- Balance problems
- Reduced reflexes
- Fatigue
- Difficulty using the hands or arms
IVIG is commonly prescribed for appropriately diagnosed CIDP patients.
For patients who respond to treatment, IVIG may help improve strength, mobility, function, or neurologic symptoms.
Some CIDP patients require recurring maintenance treatment to help maintain improvement.
Treatment frequency varies according to the prescribed product, dose, patient response, symptoms, and physician-directed treatment plan.
Eligible patients may also receive IVIG for CIDP through home infusion.
Learn more about:
Immune Thrombocytopenia
Immune thrombocytopenia, commonly called ITP, is a condition in which the immune system contributes to the destruction of platelets.
Platelets are blood cells that help the body form clots and stop bleeding.
When platelet levels become very low, patients may experience:
- Easy bruising
- Small red or purple spots on the skin
- Nosebleeds
- Bleeding gums
- Heavy menstrual bleeding
- Increased risk of more serious bleeding
IVIG may be prescribed for selected ITP patients when physicians need to increase platelet counts or help regulate the immune response.
Treatment decisions depend on factors such as:
- Platelet count
- Bleeding symptoms
- Patient age
- Medical history
- Previous treatments
- Other health conditions
- Urgency of treatment
Not every patient with ITP requires IVIG, and the prescribing specialist determines when treatment is appropriate.
Multifocal Motor Neuropathy
Multifocal Motor Neuropathy, or MMN, is a rare immune-mediated neurologic disorder involving motor nerves.
Unlike many other peripheral neuropathies, MMN primarily causes weakness rather than prominent sensory symptoms.
Patients may experience:
- Progressive weakness
- Hand weakness
- Difficulty gripping objects
- Weakness in the arms
- Muscle cramping
- Muscle twitching
IVIG is an established treatment option for certain patients with MMN.
For patients who respond, recurring immunoglobulin therapy may help improve or maintain muscle strength and function.
Because MMN may resemble other neurologic disorders, an accurate diagnosis from a neurologist is important before treatment begins.
Dermatomyositis
Dermatomyositis is an inflammatory condition that can affect both muscles and skin.
Patients may develop symptoms such as:
- Muscle weakness
- Difficulty climbing stairs
- Difficulty standing from a seated position
- Difficulty lifting the arms
- Fatigue
- Characteristic skin changes or rashes
IVIG may be prescribed for selected adults with dermatomyositis as part of a physician-directed treatment plan.
The treatment approach depends on the severity of the condition, previous treatments, symptoms, other medical conditions, and clinical response.
IVIG may be used alone in certain circumstances or alongside other therapies.
Myasthenia Gravis
Myasthenia gravis is an autoimmune neurologic condition that affects communication between nerves and muscles.
Symptoms can include:
- Muscle weakness
- Drooping eyelids
- Double vision
- Difficulty speaking
- Difficulty swallowing
- Weakness in the arms or legs
- Shortness of breath in severe cases
IVIG may be used in selected patients with myasthenia gravis, particularly when physicians need a relatively rapid immune-modulating treatment.
Treatment decisions depend on the patient’s symptoms, disease severity, medical history, and neurologist’s treatment plan.
Patients experiencing severe difficulty breathing or swallowing should seek urgent medical evaluation rather than waiting for routine infusion coordination.
Guillain-Barré Syndrome
Guillain-Barré syndrome is an acute neurologic disorder in which the immune system attacks peripheral nerves.
Symptoms may progress rapidly and can include:
- Tingling
- Weakness
- Difficulty walking
- Loss of reflexes
- Difficulty breathing in severe cases
IVIG is one of the therapies physicians may use for Guillain-Barré syndrome.
Unlike many chronic IVIG conditions, Guillain-Barré syndrome often requires acute medical evaluation and may require hospital-level care.
Home infusion is not appropriate for someone experiencing rapidly progressive neurologic symptoms or a medical emergency.
Other Autoimmune and Neurologic Conditions
Physicians may prescribe IVIG for selected conditions beyond the most common approved uses.
This is sometimes referred to as off-label prescribing.
An off-label prescription does not mean the medication is experimental. It means an approved medication is being prescribed for a use that is not specifically listed in that product’s FDA-approved labeling.
Physicians may consider IVIG for selected patients with certain:
- Autoimmune neuropathies
- Inflammatory muscle disorders
- Neurologic diseases
- Immune-mediated conditions
- Rare diseases
The decision depends on available medical evidence, clinical guidelines, individual patient circumstances, potential risks, and other treatment options.
Insurance authorization may also be more complex for some uses, and additional medical-necessity documentation may be required.
Why Can IVIG Help So Many Different Conditions?
IVIG affects the immune system in several ways.
For patients with immune deficiency, the purpose is primarily antibody replacement.
For autoimmune and inflammatory diseases, the treatment may help regulate or modify abnormal immune activity.
This explains why immunoglobulin therapy is used across several medical specialties, including:
- Immunology
- Neurology
- Hematology
- Rheumatology
- Dermatology
However, the way IVIG works and the treatment goal can differ significantly from one condition to another.
Does Every IVIG Product Treat the Same Conditions?
No.
Although IVIG products contain immunoglobulin, individual products may differ in:
- Approved indications
- Concentration
- Formulation
- Stabilizing ingredients
- Infusion instructions
- Infusion rates
- Storage requirements
- Product-specific warnings
Insurance companies may also have preferred IVIG products.
The prescribing physician and pharmacy work together to determine which prescribed product is appropriate based on the patient’s treatment plan and coverage.
Can IVIG Be Given at Home?
Many medically stable patients may be able to receive physician-prescribed IVIG at home.
Home infusion can offer:
- Less travel
- Treatment in a familiar environment
- One-on-one nursing attention
- Greater privacy
- More convenient recurring care
However, home infusion is not appropriate for every patient.
Factors that may be considered include:
- Medical stability
- Prescribed IVIG product
- Previous infusion tolerance
- History of reactions
- Required monitoring
- Home environment
- Nursing availability
- Physician recommendation
- Insurance authorization
Patients can learn more at:
Who Qualifies for Home Infusion?
What Happens Before IVIG Treatment Begins?
After Mercy Infusion receives a physician’s prescription, our team may help coordinate:
- Prescription and clinical review
- Insurance benefits verification
- Prior authorization requirements
- Clinical documentation
- IVIG product and dose
- Treatment setting
- Expected patient responsibility
- Copay or financial-assistance resources
- Medication and supplies
- Nursing or infusion-suite scheduling
Will Insurance Cover IVIG?
Coverage depends on the patient’s insurance plan, diagnosis, prescribed product, clinical documentation, and treatment setting.
An insurer may request:
- Specialist notes
- Confirmed diagnosis
- Diagnostic studies
- Laboratory results
- Previous treatment history
- Medical-necessity documentation
- Dose and frequency
- Preferred IVIG product
- Site-of-care information
Prior authorization is common for IVIG therapy.
If a request is denied, additional documentation, reconsideration, or an appeal may be available depending on the reason for denial and the patient’s plan.
Frequently Asked Questions About Conditions Treated with IVIG
What conditions are commonly treated with IVIG?
IVIG may be prescribed for conditions including certain primary immune deficiencies, CIDP, ITP, MMN, dermatomyositis, and selected other neurologic, hematologic, or autoimmune disorders.
Is IVIG only used for autoimmune diseases?
No. One of the major uses of IVIG is antibody replacement for patients with certain primary immune deficiencies.
Is IVIG used for CIDP?
Yes. IVIG is commonly prescribed for appropriately diagnosed patients with CIDP.
Can IVIG be prescribed for a condition not listed on the medication label?
Physicians may prescribe medications off-label when they determine that doing so is medically appropriate.
How often is IVIG administered?
Treatment frequency varies based on the diagnosis, product, dose, clinical response, and physician-directed treatment plan.
Can IVIG be administered at home?
Many medically appropriate patients may receive IVIG at home, subject to physician direction, clinical review, nursing availability, and insurance authorization.
Get Help Starting IVIG Therapy
If you or a loved one has been prescribed IVIG, Mercy Infusion can help coordinate:
- Insurance verification
- Prior authorization
- Medication access
- Home infusion
- Infusion-suite treatment
- Nursing
- Copay assistance
- Ongoing treatment scheduling
About the Author
April Cable is the Senior Director of Operations at Mercy Infusion, with more than 35 years of experience in specialty pharmacy billing, reimbursement, operations, and patient access. She helps patients and families navigate insurance benefits, prior authorization requirements, copay assistance, financial-support programs, and specialty medication onboarding. April works closely with prescribing providers, insurers, pharmacists, and clinical teams to help remove administrative and financial barriers to treatment.
This article is intended for general educational purposes and does not diagnose a medical condition or determine whether IVIG is appropriate for an individual patient. Treatment decisions must be made by the prescribing physician. Insurance coverage, authorization, treatment response, financial assistance, and treatment timing cannot be guaranteed.
